Back to search

Article

Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissues

2022-08-24

Abstract excerpt

<h4>Purpose: </h4> The anti-fibrotic drug pirfenidone (PFD) is currently in clinical testing for the treatment of heart failure with preserved ejection fraction, however, its effects on human cardiac cells have not been fully investigated. Therefore, we aimed to characterize the impact of PFD on human cardiac fibroblasts (CF) in 2D culture as well as in 3D engineered connective tissues (ECT). Methods We analyzed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
69b4cd03-2e72-57c3-93ec-68ae77571286
DOI
10.21203/rs.3.rs-1968389/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissuesDOI 10.21203/rs.3.rs-1968389/v1
Select a neighboring publication to make it the new centre.